Brief: Ondine Biomedical Says Topline Results Significant In Steriwave ICU Study
27/10/2025 07:35
Oct 27 (Reuters) - Ondine Biomedical Inc OBI.L: ONDINE BIOMEDICAL INC: TOPLINE RESULTS SIGNIFICANT IN STERIWAVE ICU STUDY Source text: ID:nRSa9117Ea Further company coverage: OBI.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ondine Biomedical
See all newsBrief: Ondine Lantern Phase 3 Database Lock Expected Within A Week; Top-Line Results In 1-2 Weeks
Ondine Biomedical - Leeds Drops SSIs by 78.5% in Complex Brain Surgery
Brief: Ondine Biomedical Expects 2026 To Be A Defining Year For Company
Ondine Biomedical - Notice of AGM
Ondine Biomedical - 2025 Full Year Results and Annual Report